AR Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-109,955
Closed -$2.59M 112
2023
Q1
$2.59M Buy
109,955
+36,500
+50% +$980K 0.7% 41
2022
Q4
$2.05M Sell
73,455
-36,500
-33% -$933K 0.58% 45
2022
Q3
$2.57M Hold
109,955
0.77% 41
2022
Q2
$3.71M Buy
109,955
+9,300
+9% +$326K 1.05% 32
2022
Q1
$3.52M Hold
100,655
0.89% 36
2021
Q4
$3.06M Buy
100,655
+87,202
+648% +$2.84M 0.78% 39
2021
Q3
$441K Sell
13,453
-10
-0.1% -$320 0.12% 100
2021
Q2
$407K Buy
+13,463
New +$443K 0.11% 100

Other funds holding OGN

AR Asset Management's OGN Position: Q2 2023 in Review

AR Asset Management sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 109,955 shares — an estimated $2.59M sold.

AR Asset Management first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $3.71M in Q2 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • AR Asset Management reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • AR Asset Management sold 109,955 Organon & Co shares in Q2 2023, an estimated $2.59M.
  • AR Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • AR Asset Management's Organon & Co position peaked at $3.71M in Q2 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on AR Asset Management's 13F filing for Q2 2023, filed 8 Aug 2023.